Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSIMERTINIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

66.0%
Female
34.0%
Male

Age Information

The average age of patients reporting adverse events with OSIMERTINIB is 68.2 years.

Geographic Distribution

The majority of adverse event reports for OSIMERTINIB originate from US.

Report Summary & Outcomes

27,750
Total Reports
27,750
As Primary/Secondary Suspect
12,456
Deaths Reported
5,277
Hospitalizations
757
Life-Threatening
294
Disabilities

Reporting Timeline

First adverse event report: 19510702. Most recent report: 20250926. View full timeline →

More About OSIMERTINIB

OSIMERTINIB Full Profile Reports by Year Drug Interactions